Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2015 | 1 |
2016 | 1 |
2017 | 1 |
2019 | 1 |
2020 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Effect of Early High-Dose Recombinant Human Erythropoietin on Behavior and Quality of Life in Children Aged 5 Years Born Very Preterm: Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open. 2022 Dec 1;5(12):e2245499. doi: 10.1001/jamanetworkopen.2022.45499.
JAMA Netw Open. 2022.
PMID: 36477478
Free PMC article.
Clinical Trial.
Network based statistics reveals trophic and neuroprotective effect of early high dose erythropoetin on brain connectivity in very preterm infants.
Jakab A, Ruegger C, Bucher HU, Makki M, Huppi PS, Tuura R, Hagmann C; Swiss EPO Neuroprotection Trial Group.
Jakab A, et al.
Neuroimage Clin. 2019;22:101806. doi: 10.1016/j.nicl.2019.101806. Epub 2019 Apr 1.
Neuroimage Clin. 2019.
PMID: 30991614
Free PMC article.
Clinical Trial.
Item in Clipboard
Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm Infants.
Natalucci G, Latal B, Koller B, Rüegger C, Sick B, Held L, Fauchère JC; Swiss EPO Neuroprotection Trial Group.
Natalucci G, et al.
JAMA. 2020 Dec 8;324(22):2324-2327. doi: 10.1001/jama.2020.19395.
JAMA. 2020.
PMID: 33289818
Free PMC article.
Clinical Trial.
Item in Clipboard
Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
Natalucci G, Latal B, Koller B, Rüegger C, Sick B, Held L, Bucher HU, Fauchère JC; Swiss EPO Neuroprotection Trial Group.
Natalucci G, et al.
JAMA. 2016 May 17;315(19):2079-85. doi: 10.1001/jama.2016.5504.
JAMA. 2016.
PMID: 27187300
Free article.
Clinical Trial.
Item in Clipboard
Placebo by Proxy in Neonatal Randomized Controlled Trials: Does It Matter?
Burkart TL, Kraus A, Koller B, Natalucci G, Latal B, Fauchère JC, Bucher HU, Rüegger CM; Swiss Epo Neuroprotection Trial Group.
Burkart TL, et al.
Children (Basel). 2017 May 30;4(6):43. doi: 10.3390/children4060043.
Children (Basel). 2017.
PMID: 28556820
Free PMC article.
Item in Clipboard
Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants.
O'Gorman RL, Bucher HU, Held U, Koller BM, Hüppi PS, Hagmann CF; Swiss EPO Neuroprotection Trial Group.
O'Gorman RL, et al.
Brain. 2015 Feb;138(Pt 2):388-97. doi: 10.1093/brain/awu363. Epub 2014 Dec 22.
Brain. 2015.
PMID: 25534356
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite